DDG is particularly active in the Health and Biotechnology markets.

Our customer base in this sector is varied:

• manufacturers
• laboratories, which manufacture and market drugs and health products (medical food, medicinal plants, medical devices, essential oils, dermo-cosmetics, nanomaterials, etc.).
• specialized distributors (e.g. optical eyewear)
• groups of radiologists and veterinarians
• healthcare software and platforms
• and, more generally, all those involved in the health sector

We advise them in their relations with their partners (health authorities, pharmacies) and assist them with the legislative and technological changes specific to this sector, for example in terms of transparency and marketing via the Internet, or when they wish to acquire or sell assets and protect their innovations.

We advise them on capital restructuring operations and the acquisition of investor stakes, particularly in structuring and negotiating agreements in view of the regulatory and legislative constraints associated with this type of business.

Finally, we defend their interests before the specialised authorities and the courts, both in the general field of business law and in disputes specific to this sector.